Physician profile
Bita Mostaghimi
NPI 1497760938
$3,394.91
in general payments reported to CMS, 2019-2025
23 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $63.71 · 2021: $240 · 2022: $1,054 · 2023: $355 · 2024: $551 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,007.26 | 2019-2022 | |
| Smith+Nephew, INC. | $522.15 | 2019-2025 | Collagenase Santyl, Grafix |
| Treace Medical Concepts, INC. | $347.16 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $297.64 | 2021-2025 | Nuzyra |
| Lifenet Health | $200.43 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Avita Medical Americas, LLC | $134.60 | 2025 | Recell |
| Mimedx Group, INC. | $128.33 | 2024-2025 | |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Medical Device Business Services, INC. | $90.96 | 2019 | |
| Horizon Therapeutics Plc | $86.50 | 2019-2023 | Krystexxa |
| Abbvie INC. | $81.54 | 2021-2023 | |
| Vaporox, INC. | $78.80 | 2023 | Vht-200 Wound Treatment System |
| Organogenesis INC. | $62.80 | 2020-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $29.89 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.72 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $26.59 | 2019-2021 | |
| Arthrosurface Incorporated | $25.75 | 2019 | |
| Voom Medical Devices, INC. | $24.30 | 2024 | Revcon |
| Evolution Surgical, INC | $21.78 | 2022 | |
| Urgo Medical North America, LLC | $21.03 | 2025 | Urgoclean Ag |
| Aroa Biosurgery Incorporated | $20.13 | 2019 | |
| Tactile Systems Technology INC | $19.65 | 2024 | Flexitouch Plus, Entre Plus |
| Kerecis Limited | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bita Mostaghimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.